不同程度OSAHS患者顳橫回的氫質(zhì)子波譜研究
[Abstract]:Objective: obstructive sleep apnea hypopnea syndrome (obstructive sleepapnea-hypopnea syndrome, OSAHS) and sensorineural hearing loss are common diseases in otolaryngology. In recent years, studies have shown that the incidence of sensorineural deafness in OSAHS patients is higher than that of normal people, but the mechanism is not yet clear, and it is now clinically detected for hearing. It is possible to evaluate the hearing status of the patients, but it is not possible to detect the metabolic disorders in the auditory cortex early. The present study shows that the changes in the nerve metabolites in the auditory cortex area of the patients with sensorineural hearing loss may indicate the early hearing loss, but the early metabolic changes in the auditory cortex are still lacking effective detection methods. Proton magnetic resonace spectroscopy (MRS) was first used in the medical field for the first time in 1973. MRS can selectively and accurately determine the concentration of metabolites in living tissues, and his detection sensitivity is high, and the different common frequency peaks in the coordinates are used to analyze and judge specific chemicals. There are some nuclei, such as 31P, 1H, 23NA, 13C, 19F, etc., which are used in the field of spectroscopy in the field of medicine. In the nucleus, hydrogen protons have high natural abundance and nuclear magnetic susceptibility in organic bodies. Hydrogen protons are the most used nuclei in the spectroscopic study. A variety of trace metabolites in the body, such as N- acetyl aspartic acid (NAA), choline (Cho), creatine (Cr), lactic acid (Lac), inositol (mI), glutamic acid (Glu) and glutamine (Gln), can be detected by the hydrogen proton magnetic resonance spectroscopy (1H-proton magnetic resonacespectroscopy, 1H-MRS). Magnetic resonance hydrogen proton spectroscopy (1H-MRS) was used to detect the changes of early nerve metabolites in the auditory cortex of different levels of OSAHS patients, and then the early pathological changes of the auditory cortex of the sensorineural hearing cortex in OSAHS patients were effectively judged, and the clinical experimental basis was provided for finding reliable early warning indicators.
Methods: 112 OSAHS patients and 15 healthy volunteers were randomly selected by PSG monitoring, and all the patients and healthy volunteers were treated with pure tone audiometry and auditory brainstem response analysis (ABR). The pure tone hearing threshold screening was divided into mild and moderate OSAHS bilateral deafness group, severe OSAHS bilateral deafness group, mild to moderate OSAHS unilateral deafness group and severe OSA. HS unilateral deafness group, mild and moderate OSAHS group, severe OSAHS group and normal control group, 1H-MRS detection was performed on bilateral temporal lateral auditory cortex in each group. According to the area under the peak of nerve metabolism, NAA/Cr, Cho/Cr, mI/Cr, NAA/Cho were calculated and the differences between the groups were compared, and the respiratory disorder index of OSAHS patients (Apnea Hyponea Index,) and the various gods were measured. The correlation between the metabolites NAA/Cr, Cho/Cr, and NAA/Cho, and the final ROC curve was used to determine the sensitivity and specificity of the early diagnosis of sensorineural deafness to determine the threshold of the nerve metabolites in OSAHS patients with sensorineural deafness.
Result:
The incidence of deafness in 1OSAHS patients was significantly higher than that in normal healthy people. According to the results of pure tone audiometry, the incidence of sensorineural hearing loss in OSAHS patients was 47.4%, and the incidence of group OSAHS was significantly higher than that of the general population.
AHI index of patients with 2OSAHS was negatively correlated with NAA/Cr, Cho/Cr, mI/Cr, NAA/Cho, but positively correlated with Cho/Cr.
3 the left and right ears of the normal group and the mild and moderate OSAHS group and the severe OSAHS group corresponded to the nerve metabolites NAA/Cho in the auditory cortex area, and the three decreased in turn. The difference was statistically significant (P0.05).MI/Cr, the Cho/Cr three groups were increasing in turn. The difference between the mild and moderate group and the severe group was statistically significant, but there was no statistical difference between the two groups. Learning meaning (P0.05).
4OSAHS with the deafness group and the OSAHS non deafness group, the comparison of the brain nerve metabolites in the normal control group was NAA/Cr, the NAA/Cho increased in turn, while Cho/Cr and mI/Cr decreased in turn, and the OSAHS without deafness group, the mild and moderate OSAHS accompanied by the deafness group and the severe OSAHS accompanied deafness group, NAA/Cr, NAA/Cho descended in turn. There is a difference (P0.05).
5 Compared with the normal control group, the NAA/Cr and NAA/Cho of the unilateral nervous deafness group increased in turn, Cho/Cr and mI/Cr decreased in turn, and the difference was statistically significant (P 0.05).
6 the ROC curve was used to determine the diagnostic value of the neurometabolites of OSAHS and OSAHS combined with sensorineural hearing loss (early warning value).
This study found that when the ratio of NAA to Cho was 1.93, the area under the ROC curve was 73%, the sensitivity of the diagnosis was 92%, the specificity was 78%, and the sensitivity and specificity were high. It showed that when NAA/Cho was lower than 1.93, OSAHS patients may be accompanied by neurogenic deafness, which could be used as a specific index for screening OSHAS deafness, Cho/Cr and NAA. /Cr the area under the curve is 50%, and the diagnostic accuracy is not high, so it is not considered.
Conclusion:
The incidence of sensorineural hearing loss in the 1OSAHS population was higher than that in the normal population.
2 we found that the temporal transverse gyrus of OSAHS without sensorineural hearing loss appeared in the early auditory cortex of the auditory cortex, and the hypogonadism of the patients with neurogenic deafness was more obvious than that in the patients with neurogenic deafness.
3 combined with the changes of nerve metabolites and the determination of ROC, preliminary findings suggest that NAA/Cho may be an early determinant of the occurrence of sensorineural deafness in this population.
【學(xué)位授予單位】:河北醫(yī)科大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2014
【分類號】:R766
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 陳晨;李富德;林鵬;程巖;魯宏華;李寶環(huán);;重度阻塞性睡眠呼吸暫停低通氣綜合征聽力學(xué)特征觀察[J];天津醫(yī)藥;2013年08期
2 竇曉清;陳賢明;梁永輝;張麗衛(wèi);羅碧強(qiáng);鄧意紅;;重度突發(fā)性聾患者急性期與恢復(fù)期聽皮層磁共振波譜分析[J];山東大學(xué)耳鼻喉眼學(xué)報(bào);2012年03期
3 郝彩仙;劉筠;劉學(xué)煥;許亮;王金月;鐘進(jìn);朱淼;;中重度阻塞性睡眠呼吸暫停低通氣綜合征患者懸雍垂腭咽成形術(shù)前后的多體素~1H-MRS初步研究[J];磁共振成像;2012年01期
4 孫愛華;;耳聾的臨床診斷與治療[J];中華臨床醫(yī)師雜志(電子版);2012年02期
5 陳賢明;梁永輝;陳自謙;倪萍;;突發(fā)性聾患者急性期聽皮層代謝~1H-MRS研究[J];聽力學(xué)及言語疾病雜志;2011年06期
6 沈婕;龍淼淼;沈文;祁吉;;阻塞性睡眠呼吸暫停綜合征病人腦損害的MRS研究[J];國際醫(yī)學(xué)放射學(xué)雜志;2011年04期
7 張立蘋;蔣根娣;苗迎春;譚中建;;輕度認(rèn)知功能損害患者~1H-MRS的研究[J];中國臨床醫(yī)學(xué)影像雜志;2011年01期
8 吳振綱;楊美麗;;阻塞性睡眠呼吸暫停綜合征和腦損害[J];海南醫(yī)學(xué);2010年11期
9 馬曉臣;王桂芝;王元春;馬方芹;程凱亮;;2型糖尿病患者腦海馬區(qū)氫質(zhì)子波譜的臨床分析[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2010年10期
10 夏清艷;劉鵬飛;王巍;;磁共振單體素波譜在顳葉癲癇診斷中的應(yīng)用[J];哈爾濱醫(yī)科大學(xué)學(xué)報(bào);2008年06期
本文編號:2159229
本文鏈接:http://sikaile.net/yixuelunwen/yank/2159229.html